Portal de Periódicos da CAPES

Artigo Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

Quercetin as an inhibitor of snake venom secretory phospholipase A2

2010; Elsevier BV; Volume: 189; Issue: 1-2 Linguagem: Inglês

10.1016/j.cbi.2010.10.016

1872-7786

Camila A. Cotrim, Simone Cristina Buzzo de Oliveira, Eduardo B.S. Diz Filho, Fabiana Vieira Fonseca, Lineu Baldissera, Edson Antunes, Rafael Matos Ximenes, Helena Serra Azul Monteiro, Marcelo Montenegro Rabello, Marcelo Zaldini Hernandes, Daniela de Oliveira Toyama, Marcos Hikari Toyama,

Ion channel regulation and function

As polyphenolic compounds isolated from plants extracts, flavonoids have been applied to various pharmaceutical uses in recent decades due to their anti-inflammatory, cancer preventive, and cardiovascular protective activities. In this study, we evaluated the effects of the flavonoid quercetin on Crotalus durissus terrificus secretory phospholipase A2 (sPLA2), an important protein involved in the release of arachidonic acid from phospholipid membranes. The protein was chemically modified by treatment with quercetin, which resulted in modifications in the secondary structure as evidenced through circular dichroism. In addition, quercetin was able to inhibit the enzymatic activity and some pharmacological activities of sPLA2, including its antibacterial activity, its ability to induce platelet aggregation, and its myotoxicity by approximately 40%, but was not able to reduce the inflammatory and neurotoxic activities of sPLA2. These results suggest the existence of two pharmacological sites in the protein, one that is correlated with the enzymatic site and another that is distinct from it. We also performed molecular docking to better understand the possible interactions between quercetin and sPLA2. Our docking data showed the existence of hydrogen-bonded, polar interactions and hydrophobic interactions, suggesting that other flavonoids with similar structures could bind to sPLA2. Further research is warranted to investigate the potential use of flavonoids as sPLA2 inhibitors.